Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Staying The Course: PhRMA Announces ‘Pro-Consumer’ Reform Priorities

This article was originally published in The Pink Sheet Daily

Executive Summary

Recently installed CEO Stephen Ubl presents policy solutions as industry’s best response to ongoing public criticism over high drug prices.

You may also be interested in...



PhRMA CEO: Ubl Pick Brings User Fee, Reimbursement Expertise

Steve Ubl has led AdvaMed for 10 years, raising profile of device industry on Capitol Hill and executing well-regarded public relations campaign of the kind the drug industry might need as it enters political maelstrom on pricing.

CMS-Manufacturer Discussion Of Medicare Price Negotiation Program Scheduled For 13 December

Agency reaches out to manufacturers as it develops its approach to implementing the controversial new program.

Obesity Drug Coverage In ACA Plans May Expand With Shift In Treatment Classification Standard

Current drug classification standard was originally designed for the Medicare Part D program, which does not cover obesity drugs.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS079197

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel